https://www.marketscreener.com/quote/stock/ABBVIE-INC-12136589/news/RINVOQ-upadacitinib-Approved-by-European-Commission-as-an-Oral-Treatment-for-Adults-with-Active-41126687/?utm_source=telegram&utm_medium=social&utm_campaign=share